Researchers
We support innovative research that can benefit society. Let us help you turn your ideas into meaningful progress for patients.
Our business is breakthroughs
We take cutting-edge innovations from the lab bench to the bedside, translating them into effective tools, treatments and diagnostics for people with cancer.
14
marketed drugs
£600m+
revenue from royalties and IP
150+
active licences
79
start-ups
£3bn+
raised by our start-up portfolio
Our 2023-2024 annual review is out now
See our key milestones and discover the latest innovations, start-ups, and projects set to transform the oncology sector and improve the lives of those affected by cancer.
Latest news
Drug discovery and development capabilities
Spotlight
We're committed to driving therapeutic innovation in oncology, with six drug discovery sites and one focus: accelerating the discovery and development of new therapeutics. Our expertise spans target identification, validation and clinical positioning, through Hit identification and lead optimisation to the selection of candidate drugs for regulatory development, for both small molecule and antibody modalities.
Through partnership with the Cancer Research UK Centre for Drug Development we can also offer access to the capabilities and infrastructure needed to demonstrate clinical potential.
